Pharmanutra S.p.A. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was EUR 100.2 million compared to EUR 82.72 million a year ago. Net income was EUR 12.83 million compared to EUR 15.05 million a year ago.

Basic earnings per share from continuing operations was EUR 1.33 compared to EUR 1.56 a year ago.